These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
669 related articles for article (PubMed ID: 18980244)
1. Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation. Kim JY; Kim EH; Park SS; Lim JH; Kwon TK; Choi KS J Cell Biochem; 2008 Dec; 105(6):1386-98. PubMed ID: 18980244 [TBL] [Abstract][Full Text] [Related]
2. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. Kim YH; Jung EM; Lee TJ; Kim SH; Choi YH; Park JW; Park JW; Choi KS; Kwon TK Free Radic Biol Med; 2008 Mar; 44(6):1055-68. PubMed ID: 18164688 [TBL] [Abstract][Full Text] [Related]
3. Silibinin sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5 up-regulation and down-regulation of c-FLIP and survivin. Son YG; Kim EH; Kim JY; Kim SU; Kwon TK; Yoon AR; Yun CO; Choi KS Cancer Res; 2007 Sep; 67(17):8274-84. PubMed ID: 17804742 [TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation. Kim EH; Yoon MJ; Kim SU; Kwon TK; Sohn S; Choi KS Cancer Res; 2008 Jan; 68(1):266-75. PubMed ID: 18172319 [TBL] [Abstract][Full Text] [Related]
5. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells. Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158 [TBL] [Abstract][Full Text] [Related]
6. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells. Liu X; Yue P; Chen S; Hu L; Lonial S; Khuri FR; Sun SY Cancer Res; 2007 May; 67(10):4981-8. PubMed ID: 17510429 [TBL] [Abstract][Full Text] [Related]
7. Withaferin A sensitizes TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. Lee TJ; Um HJ; Min do S; Park JW; Choi KS; Kwon TK Free Radic Biol Med; 2009 Jun; 46(12):1639-49. PubMed ID: 19345731 [TBL] [Abstract][Full Text] [Related]
8. The cyclin-dependent kinase inhibitor flavopiridol sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis. Miyashita K; Shiraki K; Fuke H; Inoue T; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T Int J Mol Med; 2006 Aug; 18(2):249-56. PubMed ID: 16820931 [TBL] [Abstract][Full Text] [Related]
9. Over-expression of Reticulon 3 (RTN3) enhances TRAIL-mediated apoptosis via up-regulation of death receptor 5 (DR5) and down-regulation of c-FLIP. Lee JT; Lee TJ; Kim CH; Kim NS; Kwon TK Cancer Lett; 2009 Jul; 279(2):185-92. PubMed ID: 19250737 [TBL] [Abstract][Full Text] [Related]
10. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation. Shigeno M; Nakao K; Ichikawa T; Suzuki K; Kawakami A; Abiru S; Miyazoe S; Nakagawa Y; Ishikawa H; Hamasaki K; Nakata K; Ishii N; Eguchi K Oncogene; 2003 Mar; 22(11):1653-62. PubMed ID: 12642868 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis. Hetschko H; Voss V; Seifert V; Prehn JH; Kögel D FEBS J; 2008 Apr; 275(8):1925-36. PubMed ID: 18341587 [TBL] [Abstract][Full Text] [Related]
12. TRAIL apoptosis is enhanced by quercetin through Akt dephosphorylation. Kim YH; Lee YJ J Cell Biochem; 2007 Mar; 100(4):998-1009. PubMed ID: 17031854 [TBL] [Abstract][Full Text] [Related]
13. Flavopiridol induces cellular FLICE-inhibitory protein degradation by the proteasome and promotes TRAIL-induced early signaling and apoptosis in breast tumor cells. Palacios C; Yerbes R; López-Rivas A Cancer Res; 2006 Sep; 66(17):8858-69. PubMed ID: 16951203 [TBL] [Abstract][Full Text] [Related]
14. Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway. Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH Biochem Pharmacol; 2009 Apr; 77(8):1328-36. PubMed ID: 19426671 [TBL] [Abstract][Full Text] [Related]
15. 5, 7-Dimethoxyflavone sensitizes TRAIL-induced apoptosis through DR5 upregulation in hepatocellular carcinoma cells. Yang JF; Cao JG; Tian L; Liu F Cancer Chemother Pharmacol; 2012 Jan; 69(1):195-206. PubMed ID: 21660448 [TBL] [Abstract][Full Text] [Related]
16. Berberine sensitizes TRAIL-induced apoptosis through proteasome-mediated downregulation of c-FLIP and Mcl-1 proteins. Lee SJ; Noh HJ; Sung EG; Song IH; Kim JY; Kwon TK; Lee TJ Int J Oncol; 2011 Feb; 38(2):485-92. PubMed ID: 21170508 [TBL] [Abstract][Full Text] [Related]
17. The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation. Carlisi D; Lauricella M; D'Anneo A; Emanuele S; Angileri L; Di Fazio P; Santulli A; Vento R; Tesoriere G Eur J Cancer; 2009 Sep; 45(13):2425-38. PubMed ID: 19643600 [TBL] [Abstract][Full Text] [Related]
18. Capsaicin sensitizes TRAIL-induced apoptosis through Sp1-mediated DR5 up-regulation: involvement of Ca(2+) influx. Moon DO; Kang CH; Kang SH; Choi YH; Hyun JW; Chang WY; Kang HK; Koh YS; Maeng YH; Kim YR; Kim GY Toxicol Appl Pharmacol; 2012 Feb; 259(1):87-95. PubMed ID: 22200406 [TBL] [Abstract][Full Text] [Related]
19. Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells. Taniguchi H; Yoshida T; Horinaka M; Yasuda T; Goda AE; Konishi M; Wakada M; Kataoka K; Yoshikawa T; Sakai T Cancer Res; 2008 Nov; 68(21):8918-27. PubMed ID: 18974136 [TBL] [Abstract][Full Text] [Related]
20. Acrolein sensitizes human renal cancer Caki cells to TRAIL-induced apoptosis via ROS-mediated up-regulation of death receptor-5 (DR5) and down-regulation of Bcl-2. Yang ES; Woo SM; Choi KS; Kwon TK Exp Cell Res; 2011 Nov; 317(18):2592-601. PubMed ID: 21854768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]